Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication
View Patent ↗The present invention features antigen binding protein that bind to a SR-BI target region identified herein as a region involved in HCV E2 binding. Identified target regions are regions bound by a single-chain antibody of SEQ ID NOs: 1, 2, 3 or 4.
1. An antibody or antigen binding fragment thereof that comprises a first variable region and a second variable region, wherein either:
a) said first variable region is a V h region comprising a first CDR comprising amino acids 31-35 of SEQ ID NO: 1, a second CDR comprising amino acids 50-66 of SEQ ID NO: 1, and a third CDR comprising amino acids 99-108 of SEQ ID NO: 1; and said second variable region is a V 1 region comprising a first CDR comprising amino acids 158-170 of SEQ ID NO: 1, a second CDR comprising amino acids 186-192 of SEQ ID NO: 1, and a third CDR comprising amino acids 225-235 of SEQ ID NO: 1;
b) said first variable region is a V h region comprising a first CDR comprising amino acids 31-37 of SEQ ID NO: 2, a second CDR comprising amino acids 52-67 of SEQ ID NO: 2, and a third CDR comprising the amino acids 100-114 of SEQ ID NO: 2; and said second variable region is a V 1 region comprising a first CDR comprising amino acids 164-176 of SEQ ID NO: 2, a second CDR comprising amino acids 192-198 of SEQ ID NO: 2, and a third CDR comprising amino acids 231-241 of SEQ ID NO: 2;
c) said first variable region is a V h region comprising a first CDR comprising amino acids 31-35 of SEQ ID NO: 3, a second CDR comprising amino acids 50-66 of SEQ ID NO: 3, and a third CDR comprising amino acids 99-108 of SEQ ID NO: 3; and said second variable region is a V 1 region comprising a first CDR comprising amino acids 158-170 of SEQ ID NO: 3, a second CDR comprising amino acids 186-192 of SEQ ID NO: 3, and a third CDR comprising amino acids 225-235 of SEQ ID NO: 3; or
d) said first variable region is a V h region comprising a first CDR comprising amino acids 31-35 of SEQ ID NO: 4, a second CDR comprising amino acids 50-66 of SEQ ID NO: 4, and a third CDR comprising amino acids 99-108 of SEQ ID NO: 4; and said second variable region is a V 1 region comprising a first CDR comprising amino acids 158-170 of SEQ ID NO: 4, a second CDR comprising amino acids 186-192 of SEQ ID NO: 4, and a third CDR comprising amino acids 225-235 of SEQ ID NO: 4.
2. The antibody or antigen binding fragment thereof of claim 1 , wherein either:
a) said first variable region consists of amino acids 1-119 of SEQ ID NO: 1 and said second variable region consists of amino acids 136-245 of SEQ ID NO: 1;
b) said first variable region consists of amino acids 1-125 of SEQ ID NO: 2 and said second variable region consists of amino acids 142-251 of SEQ ID NO: 2;
c) said first variable region consists of amino acids 1-119 of SEQ ID NO: 3 and said second variable region consists of amino acids 136-245 of SEQ ID NO: 3; or
d) said first variable region consists of amino acids 1-119 of SEQ ID NO: 4 and said second variable region consists of amino acids 136-245 of SEQ ID NO: 4.
3. The antibody or antigen binding fragment thereof of claim 1 , wherein said antibody is a monoclonal antibody.
4. The antibody or antigen binding fragment thereof of claim 1 , wherein said binding protein is a single chain antibody wherein said first variable region is joined to said second variable region by an amino acid linker about 5 to 16 amino acids in length.
5. The antibody or antigen binding fragment thereof of claim 4 , wherein either:
a) said first variable region consists of amino acids 1-119 of SEQ ID NO: 1 and said second variable region consists of amino acids 136-245 of SEQ ID NO: 1;
b) said first variable region consists of amino acids 1-125 of SEQ ID NO: 2 and said second variable region consists of amino acids 142-251 of SEQ ID NO: 2;
c) said first variable region consists of amino acids 1-119 of SEQ ID NO: 3 and said second variable region consists of amino acids 136-245 of SEQ ID NO: 3; or
d) said first variable region consists of amino acids 1-119 of SEQ ID NO: 4 and said second variable region consists of amino acids 136-245 of SEQ ID NO: 4.
6. An isolated single chain antibody that is any of SEQ ID NOs:1-4.